标题
Tumor-derived extracellular vesicles in melanoma immune response and immunotherapy
作者
关键词
-
出版物
BIOMEDICINE & PHARMACOTHERAPY
Volume 156, Issue -, Pages 113790
出版商
Elsevier BV
发表日期
2022-10-13
DOI
10.1016/j.biopha.2022.113790
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Exosome-mediated delivery of transforming growth factor-β receptor 1 kinase inhibitors and toll-like receptor 7/8 agonists for combination therapy of tumors
- (2022) Joo Hang Lee et al. Acta Biomaterialia
- Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma
- (2022) Simona Serratì et al. Molecular Cancer
- A phase I study of the safety and efficacy of talimogene laherparepvec in Japanese patients with advanced melanoma
- (2022) Naoya Yamazaki et al. CANCER SCIENCE
- Tumour‐associated antigenic peptides are present in the HLA class I ligandome of cancer cell line derived extracellular vesicles
- (2022) Pankaj Kumar et al. IMMUNOLOGY
- Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment
- (2022) Zijie Xu et al. MOLECULAR THERAPY
- Challenges and directions in studying cell–cell communication by extracellular vesicles
- (2022) Guillaume van Niel et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- TIM-3 shuttled by MV3 cells-secreted exosomes inhibits CD4+ T cell immune function and induces macrophage M2 polarization to promote the growth and metastasis of melanoma cells
- (2022) Xinghui Li et al. Translational Oncology
- Agents of cancer immunosurveillance: HSPs and dsDNA
- (2022) Devanshi A. Nayak et al. TRENDS IN IMMUNOLOGY
- Rescuing Cancer Immunity by Plasma Exchange in Metastatic Melanoma (ReCIPE-M1): protocol for a single-institution, open-label safety trial of plasma exchange to clear sPD-L1 for immunotherapy
- (2022) Tara M Davidson et al. BMJ Open
- A Hoechst Reporter Enables Visualization of Drug Engagement In Vitro and In Vivo: Toward Safe and Effective Nanodrug Delivery
- (2022) Takuya Miyazaki et al. ACS Nano
- Cancer vaccines: Building a bridge over troubled waters
- (2022) MacLean C. Sellars et al. CELL
- Development of nanocubosomes co-loaded with dual anticancer agents curcumin and temozolomide for effective Colon cancer therapy
- (2022) Yosif Almoshari et al. DRUG DELIVERY
- Regulatory T‐cell development in the tumor microenvironment
- (2022) Kota Itahashi et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- HRS phosphorylation drives immunosuppressive exosome secretion and restricts CD8+ T-cell infiltration into tumors
- (2022) Lei Guan et al. Nature Communications
- Engineering micro oxygen factories to slow tumour progression via hyperoxic microenvironments
- (2022) Weili Wang et al. Nature Communications
- Emerging concepts regarding pro- and anti tumor properties of B cells in tumor immunity
- (2022) You Qin et al. Frontiers in Immunology
- Baseline and post-treatment biomarkers of resistance to anti-PD-1 therapy in acral and mucosal melanoma: an observational study
- (2022) Irene M. Shui et al. Journal for ImmunoTherapy of Cancer
- Therapeutic Cancer Vaccines—Antigen Discovery and Adjuvant Delivery Platforms
- (2022) Neftali Ortega Alarcon et al. Pharmaceutics
- Melanoma-derived small extracellular vesicles remodel the systemic onco-immunity via disrupting hematopoietic stem cell proliferation and differentiation
- (2022) Zhimin Du et al. CANCER LETTERS
- CAR NK cell therapy in hematologic malignancies and solid tumors; obstacles and strategies to overcome the challenges
- (2022) Ayda Baghery Saghchy Khorasani et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
- (2021) Eryn Blass et al. Nature Reviews Clinical Oncology
- Extracellular vesicles in cancer diagnostics and therapeutics
- (2021) Adeeb Shehzad et al. PHARMACOLOGY & THERAPEUTICS
- Inhibition of xCT suppresses the efficacy of anti-PD-1/L1 melanoma treatment through exosomal PD-L1-induced macrophage M2 polarization
- (2021) Nian Liu et al. MOLECULAR THERAPY
- Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti–PD-1 Therapy Efficacy
- (2021) Anne Montfort et al. Cancer Immunology Research
- Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis
- (2021) Shichuan Hu et al. Acta Biomaterialia
- PDL1‐positive exosomes suppress antitumor immunity by inducing tumor‐specific CD8 + T cell exhaustion during metastasis
- (2021) Ji Chen et al. CANCER SCIENCE
- Imaging dendritic cell functions*
- (2021) Berislav Bošnjak et al. IMMUNOLOGICAL REVIEWS
- Type 1 conventional dendritic cells: ontogeny, function, and emerging roles in cancer immunotherapy
- (2021) Shengbo Zhang et al. TRENDS IN IMMUNOLOGY
- Extracellular vesicles and immunogenic stress in cancer
- (2021) Qi Wu et al. Cell Death & Disease
- A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis
- (2021) Guohao Wang et al. Nature Communications
- Hsp70-containing extracellular vesicles are capable of activating of adaptive immunity in models of mouse melanoma and colon carcinoma
- (2021) Elena Y. Komarova et al. Scientific Reports
- Tumor-derived extracellular vesicles regulate tumor-infiltrating regulatory T cells via the inhibitory immunoreceptor CD300a
- (2021) Yuta Nakazawa et al. eLife
- Novel phosphatidylserine-binding molecule enhances antitumor T-cell responses by targeting immunosuppressive exosomes in human tumor microenvironments
- (2021) Maulasri Bhatta et al. Journal for ImmunoTherapy of Cancer
- ALIX- and ESCRT-III–dependent sorting of tetraspanins to exosomes
- (2020) Jorge Larios et al. JOURNAL OF CELL BIOLOGY
- Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cells
- (2020) Priyanka Sharma et al. Scientific Reports
- Melanoma-Derived Exosomal miR-125b-5p Educates Tumor Associated Macrophages (TAMs) by Targeting Lysosomal Acid Lipase A (LIPA)
- (2020) Dennis Gerloff et al. Cancers
- Extracellular vesicles as drug delivery systems: Why and how?
- (2020) Omnia M. Elsharkasy et al. ADVANCED DRUG DELIVERY REVIEWS
- Acquired Resistance to Immune Checkpoint Inhibitors
- (2020) Adam J. Schoenfeld et al. CANCER CELL
- Advanced drug delivery 2020 and beyond: Perspectives on the future
- (2020) You Han Bae et al. ADVANCED DRUG DELIVERY REVIEWS
- Exosome-Containing Preparations From Postirradiated Mouse Melanoma Cells Delay Melanoma Growth In Vivo by a Natural Killer Cell–Dependent Mechanism
- (2020) Kishore Kumar Jella et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Exploring the NK cell platform for cancer immunotherapy
- (2020) Jacob A. Myers et al. Nature Reviews Clinical Oncology
- PPARα Inhibition Overcomes Tumor-Derived Exosomal Lipid-Induced Dendritic Cell Dysfunction
- (2020) Xiaozhe Yin et al. Cell Reports
- Non-coding RNA derived from extracellular vesicles in cancer immune escape: Biological functions and potential clinical applications
- (2020) Mingyao Huang et al. CANCER LETTERS
- Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature
- (2019) Xinguo Jiang et al. CIRCULATION
- Reassessment of Exosome Composition
- (2019) Dennis K. Jeppesen et al. CELL
- Melanoma extracellular vesicles generate immunosuppressive myeloid cells by PD-L1 upregulation via TLR4 signaling
- (2019) Viktor Fleming et al. CANCER RESEARCH
- MiR-135-5p-p62 Axis Regulates Autophagic Flux, Tumorigenic Potential, and Cellular Interactions Mediated by Extracellular Vesicles During Allergic Inflammation
- (2019) Misun Kim et al. Frontiers in Immunology
- Glycan-Modified Melanoma-Derived Apoptotic Extracellular Vesicles as Antigen Source for Anti-Tumor Vaccination
- (2019) Horrevorts et al. Cancers
- The many functions of ESCRTs
- (2019) Marina Vietri et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment
- (2019) Yangjing Zhao et al. Cellular & Molecular Immunology
- Regulation of the Cell Biology of Antigen Cross-Presentation
- (2018) J. Magarian Blander Annual Review of Immunology
- Myeloid-derived suppressor cells coming of age
- (2018) Filippo Veglia et al. NATURE IMMUNOLOGY
- Tumor-associated macrophages-derived exosomes promote the migration of gastric cancer cells by transfer of functional Apolipoprotein E
- (2018) Peiming Zheng et al. Cell Death & Disease
- Melanoma-released exosomes directly activate the mitochondrial apoptotic pathway of CD4+ T cells through their microRNA cargo
- (2018) Ji Zhou et al. EXPERIMENTAL CELL RESEARCH
- Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma
- (2018) Veronica Huber et al. JOURNAL OF CLINICAL INVESTIGATION
- Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication
- (2018) Mathilde Mathieu et al. NATURE CELL BIOLOGY
- Enhanced Class I Tumor Antigen Presentation via Cytosolic Delivery of Exosomal Cargos by Tumor-Cell-Derived Exosomes Displaying a pH-Sensitive Fusogenic Peptide
- (2017) Masaki Morishita et al. MOLECULAR PHARMACEUTICS
- Melanoma exosomes deliver a complex biological payload that upregulates PTPN11 to suppress T lymphocyte function
- (2017) Yueting Wu et al. Pigment Cell & Melanoma Research
- Human Melanoma-Derived Extracellular Vesicles Regulate Dendritic Cell Maturation
- (2017) Rachel L. G. Maus et al. Frontiers in Immunology
- Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation
- (2017) Marek Wieczorek et al. Frontiers in Immunology
- Melanoma exosome induction of endothelial cell GM-CSF in pre-metastatic lymph nodes may result in different M1 and M2 macrophage mediated angiogenic processes
- (2016) Joshua L. Hood MEDICAL HYPOTHESES
- Apoptotic epithelial cells control the abundance of Treg cells at barrier surfaces
- (2016) Chigusa Nakahashi-Oda et al. NATURE IMMUNOLOGY
- Tumour cell-derived exosomes endow mesenchymal stromal cells with tumour-promotion capabilities
- (2016) L Y Lin et al. ONCOGENE
- SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions
- (2016) F. Pucci et al. SCIENCE
- Myeloid-derived suppressor cells and tumor escape from immune surveillance
- (2016) Viktor Umansky et al. Seminars in Immunopathology
- Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
- (2016) Vincenzo Bronte et al. Nature Communications
- T Cell Antigen Receptor Recognition of Antigen-Presenting Molecules
- (2015) Jamie Rossjohn et al. Annual Review of Immunology
- Myeloid-derived suppressor cell heterogeneity in human cancers
- (2014) Samantha Solito et al. Annals of the New York Academy of Sciences
- Plasma-derived MHC class II+ exosomes from tumor-bearing mice suppress tumor antigen-specific immune responses
- (2012) Chenjie Yang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Melanoma cell-derived exosomes alter macrophage and dendritic cell functions in vitro
- (2012) Annamaria Marton et al. IMMUNOLOGY LETTERS
- Multivesicular Endosome Biogenesis in the Absence of ESCRTs
- (2009) Susanne Stuffers et al. TRAFFIC
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started